MHRA Updated Guidance on Managing Clinical Trials During Coronavirus (COVID-19)

On 16 March 2021 the UK MHRA updated the guidance on managing clinical trials during COVID-19.

The updated guidance added new information to the 'Management of COVID-19 vaccination for subjects participating in ongoing non-COVID-19 clinical trials' section. The changes cover information on the trial participant continuing to receive the deployed vaccine, and that trial participants must be able to contact the trial team when they receive an invitation to receive a deployed vaccine.

Read more online 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /